Ann Surg Oncol
- GREENE AC, Ziegler O, Pameijer CR, Shen C, et al
ASO Author Reflections: Exploring the Impact-Medicaid Expansion and Improved
Survival in Patients with Cutaneous Melanoma.
Ann Surg Oncol. 2024 Apr 22. doi: 10.1245/s10434-024-15286.
BMC Cancer
- ZHANG Y, Zheng J, Chen M, Zhao S, et al
Modulating DNA damage response in uveal melanoma through embryonic stem cell
microenvironment.
BMC Cancer. 2024;24:519.
Br J Dermatol
- NIELSEN JB, Kristiansen IS, Thapa S
Increasing melanoma incidence with unchanged mortality: more sunshine, better
treatment, increased diagnostic activity, overdiagnosis or lowered diagnostic
threshold?
Br J Dermatol. 2024 Apr 24:ljae175. doi: 10.1093.
Melanoma Res
- SHAH H, Parisi R, Everdell E, Feustel P, et al
The effect of COVID-19 on early melanoma detection.
Melanoma Res. 2024;34:283-284.
- GAO Y, Wang Y, Luo Y, Zhang Y, et al
Pretreatment CD8+PD-1+ to CD4+PD-1+ ratio is associated with the prognosis of
advanced melanoma patients treated with PD-1 inhibitors.
Melanoma Res. 2024 Apr 22. doi: 10.1097/CMR.0000000000000972.
Oncol Rep
- SHI J, Guo B, Hui Q, Chang P, et al
[Retracted] Fangchinoline suppresses growth and metastasis of melanoma cells by
inhibiting the phosphorylation of FAK.
Oncol Rep. 2024;51:81.
PLoS Comput Biol
- LIU C, Xiao K, Yu C, Lei Y, et al
A probabilistic knowledge graph for target identification.
PLoS Comput Biol. 2024;20:e1011945.
PLoS One
- COURTENAY LA, Barbero-Garcia I, Martinez-Lastras S, Del Pozo S, et al
Near-infrared hyperspectral imaging and robust statistics for in vivo
non-melanoma skin cancer and actinic keratosis characterisation.
PLoS One. 2024;19:e0300400.
- DHEIN ES, Heikkila U, Oevermann A, Blatter S, et al
Incidence rates of the most common canine tumors based on data from the Swiss
Canine Cancer Registry (2008 to 2020).
PLoS One. 2024;19:e0302231.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016